Effect of irbesartan,angiotensin 2 receptor antagonist(ARB)for urinary marker of the hypertensive patients

Trial Profile

Effect of irbesartan,angiotensin 2 receptor antagonist(ARB)for urinary marker of the hypertensive patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2015

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 15 Sep 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan
    • 17 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top